The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
May 2nd 2024
The screenings should be conducted every other year, beginning at age 40 and continuing through age 74, according to the new recommendation.
First-Line Combo Immunotherapy Improves PFS in High TMB Non-Small Cell Lung Cancer
February 5th 2018The combination of nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival (PFS) compared with chemotherapy in treatment-naïve patients with high tumor mutation burden (TMB) non–small cell lung cancer (NSCLC).
Read More